Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 8;12(6):e061211.
doi: 10.1136/bmjopen-2022-061211.

Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study

Affiliations

Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study

Kristen Pickles et al. BMJ Open. .

Abstract

Objectives: To explore experiences of women who identified themselves as having a possible breast cancer overdiagnosis.

Design: Qualitative interview study using key components of a grounded theory analysis.

Setting: International interviews with women diagnosed with breast cancer and aware of the concept of overdiagnosis.

Participants: Twelve women aged 48-77 years from the UK (6), USA (4), Canada (1) and Australia (1) who had breast cancer (ductal carcinoma in situ n=9, (invasive) breast cancer n=3) diagnosed between 2004 and 2019, and who were aware of the possibility of overdiagnosis. Participants were recruited via online blogs and professional clinical networks.

Results: Most women (10/12) became aware of overdiagnosis after their own diagnosis. All were concerned about the possibility of overdiagnosis or overtreatment or both. Finding out about overdiagnosis/overtreatment had negative psychosocial impacts on women's sense of self, quality of interactions with medical professionals, and for some, had triggered deep remorse about past decisions and actions. Many were uncomfortable with being treated as a cancer patient when they did not feel 'diseased'. For most, the recommended treatments seemed excessive compared with the diagnosis given. Most found that their initial clinical teams were not forthcoming about the possibility of overdiagnosis and overtreatment, and many found it difficult to deal with their set management protocols.

Conclusion: The experiences of this small and unusual group of women provide rare insight into the profound negative impact of finding out about overdiagnosis after breast cancer diagnosis. Previous studies have found that women valued information about overdiagnosis before screening and this knowledge did not reduce subsequent screening uptake. Policymakers and clinicians should recognise the diversity of women's perspectives and ensure that women are adequately informed of the possibility of overdiagnosis before screening.

Keywords: breast imaging; breast tumours; international health services; public health; qualitative research; quality in health care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AB, KM, JH, BN, KP had financial support from the National Health & Medical Research Council, Australia for the submitted work. JSV reports a grant from the Health Technology Assessment Programme of National Institute of Health Research, UK during the conduct of the study. JSV received payment from Carl Zeiss for travel to meetings and honoraria outside the submitted work. AB is a member and Co-Chair of the Scientific Committee for the Preventing Overdiagnosis International Conferences. KP, BN and JH are members of the early career researcher committee for the Preventing Overdiagnosis International Conferences.

References

    1. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605–13. 10.1093/jnci/djq099 - DOI - PubMed
    1. Marmot MG, Altman DG, Cameron DA, et al. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013;108:2205–40. 10.1038/bjc.2013.177 - DOI - PMC - PubMed
    1. Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ 2015;350:g7773. 10.1136/bmj.g7773 - DOI - PMC - PubMed
    1. Glasziou PP, Jones MA, Pathirana T, et al. Estimating the magnitude of cancer overdiagnosis in Australia. Med J Aust 2020;212:163–8. 10.5694/mja2.50455 - DOI - PMC - PubMed
    1. Bewley S, Blennerhassett M, Payne M. Cost of extending the NHS breast screening age range in England. BMJ 2019;365:l1293. 10.1136/bmj.l1293 - DOI - PubMed

Publication types